Director/PDMR Shareholding

HeiQ PLC

16 September 2024

 

16 September 2024

HeiQ Plc

("HeiQ" or the "Company" or the "Group")

Director's Dealings

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, announces that Carlo Centonze, Chief Executive Officer, has purchased 1,000,000 ordinary shares of 5p each in the Company ("Ordinary Shares") at a price of 5p per share.

Further information is set out below pursuant to the requirements of the UK Market Abuse Regulation.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mr. Carlo Centonze
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	HeiQ plc
b)	LEI	213800IGT65IMJDO4S03
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 5p each ISIN: GB00BN2CJ299
b)	Nature of the transaction	Purchase of ordinary shares
c)	Price(s) and volume(s)	Date Price(s) Volume(s) 12 September 2024 5p per share 500,000 13 September 2024 5p per share 500,000
d)	Aggregated information - Aggregated volume - Price	1,000,000 shares 5p per share
e)	Date of the transaction	12th and 13th of September 2024
f)	Place of the transaction	London Stock Exchange, Main Market

For further information, please contact:

HeiQ Plc Carlo Centonze (CEO)	[phone]
Cavendish Capital Markets Limited (Broker) Stephen Keys / Callum Davidson	[phone]
SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton / Tom Carnegie	[phone] [e-mail]

About HeiQ

Founded in 2005, HeiQ is a Swiss-based international company that is a global leader in biotech ingredients and specialty chemicals for diverse applications such as textiles, flooring, building materials, glass, plastics, probiotic cleaning, cosmetics, and more. Working with more than 1000 partners in over 60 countries, our goal is to infuse ordinary products with extraordinary qualities, offering our co-creation partners sustainable and disruptive solutions across industries.

Our business model focuses on the commercialization of existing and as well as the incubation of new technologies, driving shareholder value through sales growth, entry into lucrative markets, and disruptive innovation. This model consists of three distinct technology ventures, being HeiQ AeoniQ, HeiQ Xpectra, and HeiQ GrapheneX, and three growth-orientated business units being HeiQ Textiles & Flooring, HeiQ Life Sciences, and HeiQ Antimicrobials.

We have a robust track record of innovation, with over 200 technologies developed in partnership with 300 major brands, including Hanes, Burberry, HUGO BOSS, Lycra, Zara, Itochu, Bosch Siemens, Ecolab, Woellner, Americhem, Lixil, and many more. Our global team comprises about 200 professionals from 30 nationalities across five continents. We're committed to shaping a future where everyday products drive positive change, one innovation at a time.

To learn more about HeiQ and our innovative solutions, visit www.heiq.com.

 

END